Event Calendar - 2024 Events

Event Calendar - 2024 Events

March 20, 2025
Zurich, Switzerland

March 12, 2025
Miami, USA

March 07, 2025
Basel, Switzerland

Visit the General Meetings section

March 04, 2025
Boston, USA

March 04, 2025
London, UK

January 14, 2025 
San Francisco, USA

Novartis CEO Vas Narasimhan presented at the J.P. Morgan Healthcare Conference.

Download the presentation (PDF 2.3 MB)

Download the podcast (MP3 18 MB)

December 09, 2024
Virtual event

Novartis 11th annual ESG investor event

Watch the webcast

Download the presentation (PDF 1.9 MB)

December 04, 2024
Miami, USA

November 21, 2024
London, UK

Read the media release

Watch the webcast

Download the webcast agenda (PDF 0.1 MB)

Download the speaker slides (PDF 0.8 MB)

Download the CEO presentation (PDF 1.2 MB)

Download the breakout slides (PDF 0.3 MB)

November 13, 2024
London, UK

November 12, 2024
Ranchos Palo Verdes, USA

November 12, 2024
Boston, USA

November 08, 2024
Zurich, Switzerland

October 29, 2024
Basel, Switzerland

Media release:
English (PDF 0.4 MB) | Deutsch (PDF 0.5 MB)
Interim financial report (PDF 0.6 MB)

Watch the webcast

Download the podcast (MP3 31 MB)

Download the presentation (PDF 6.8 MB)

Read the transcript

Novartis Q3 2024 impact and sustainability update (PDF 0.6 MB)

October 28, 2024
Virtual

Download the presentation (PDF 1.4 MB)

Watch the webcast

Download the podcast (MP3 30 MB)

September 26, 2024
Munich, Germany

September 25, 2024
Paris, France

September 18, 2024
London, UK

September 05, 2024
New York, USA

July 18, 2024
Basel, Switzerland

Media release:
English (PDF 0.5 MB) | Deutsch (PDF 0.5 MB) | Français (PDF 0.5 MB)

Interim financial report (PDF 0.5 MB

Watch the webcast

Download the podcast (MP3 34 MB)

Download the presentation (PDF 5.5 MB)

Read the transcript

Novartis Q2 2024 impact and sustainability update (PDF 0.9 MB)

June 27, 2024
Lyon, France

June 20, 2024
London, UK

June 19, 2024
London, UK

June 11, 2024
Miami, USA

June 06, 2024
New York, USA

June 02, 2024
Chicago, USA

Watch the webcast

Download the presentation (PDF 1.0 MB)

Read the media release: Novartis Scemblix® Phase III data first to show superior efficacy with a favorable safety and tolerability profile vs. standard-of-care TKIs in adults with newly diagnosed CML

May 29, 2024
New York, USA

May 23, 2024
Frankfurt, Germany

May 21, 2024
New York, USA

May 20, 2024
Brooklyn, USA

May 15, 2024
Toronto, Canada

May 15, 2024
Las Vegas, USA

April 23, 2024
Basel, Switzerland

Media release:
English (PDF 0.3 MB) | Deutsch (PDF 0.3 MB) | Français (PDF 0.4 MB)

Interim financial report (PDF 0.4 MB)

Watch the webcast

Download the podcast (MP3 30 MB)

Download the presentation (PDF 6.0 MB)

Read the transcript

Novartis Q1 2024 impact and sustainability update (PDF 1.4 MB)

March 26, 2024
Virtual

March 26, 2024
Paris, France

March 21, 2024
Zurich, Switzerland

March 06, 2024
Boston, USA

March 05, 2024
Basel, Switzerland

Visit the General Meetings section

February 28, 2024
London, UK

January 31, 2024
Basel, Switzerland

Media release:
English (PDF 0.3 MB) | Deutsch (PDF 0.3 MB) | Français (PDF 0.3 MB)

Condensed financial report (PDF 0.6 MB)

Download the podcast (MP3 34 MB)

Download the presentation (PDF 5.5 MB)

Read the transcript

Novartis Q4 2023 impact and sustainability update (PDF 0.6 MB)

2023 epidemiology data (PDF 1.1 MB)

January 08, 2024
San Francisco, USA 

Download the presentation (PDF 1.3 MB)

Download the podcast (MP3 18 MB)

Read the featured news

Source URL: https://prod1.novartis.com/node/662281

List of links present in page
  1. https://prod1.novartis.com/node/662281
  2. https://prod1.novartis.com/investors/shareholder-information/general-meetings
  3. https://prod1.novartis.com/sites/novartis_com/files/novartis-investor-presentation-jpm-2025-growth-story.pdf
  4. https://prod1.novartis.com/sites/novartis_com/files/2025-01/novartis-investor-presentation-jpm-2025-growth-story.mp3
  5. https://novartis.webcasts.com/starthere.jsp?ei=1689776&tp_key=9312b9a422
  6. https://prod1.novartis.com/sites/novartis_com/files/2024-12-novartis-impact-sustainability.pdf
  7. https://prod1.novartis.com/news/media-releases/novartis-upgrades-mid-term-guidance-and-highlights-deep-pipeline-core-therapeutic-areas-drive-long-term-growth
  8. https://edge.media-server.com/mmc/p/mfs4d9bz
  9. https://prod1.novartis.com/sites/novartis_com/files/meet-novartis-management-2024-agenda.pdf
  10. https://prod1.novartis.com/sites/novartis_com/files/meet-novartis-management-2024-speaker-slides.pdf
  11. https://prod1.novartis.com/sites/novartis_com/files/meet-novartis-management-2024-ceo-presentation.pdf
  12. https://prod1.novartis.com/sites/novartis_com/files/meet-novartis-management-2024-breakout-slides.pdf
  13. https://prod1.novartis.com/sites/novartis_com/files/q3-2024-media-release-en.pdf
  14. https://prod1.novartis.com/sites/novartis_com/files/q3-2024-media-release-de.pdf
  15. https://prod1.novartis.com/sites/novartis_com/files/2024-10-interim-financial-report-en.pdf
  16. https://edge.media-server.com/mmc/p/3hsrpsa4
  17. https://prod1.novartis.com/sites/novartis_com/files/2024-10/q3-2024-investor-presentation.mp3
  18. https://prod1.novartis.com/sites/novartis_com/files/q3-2024-investor-presentation.pdf
  19. https://prod1.novartis.com/investors/financial-data/quarterly-results/2024-q3-transcript
  20. https://prod1.novartis.com/sites/novartis_com/files/novartis-q3-2024-impact-and-sustainability-update.pdf
  21. https://prod1.novartis.com/sites/novartis_com/files/2024-10-novartis-renal-portfolio-presentation.pdf
  22. https://edge.media-server.com/mmc/p/d4yyo26k
  23. https://prod1.novartis.com/sites/novartis_com/files/2024-10/2024-10-novartis-renal-portfolio-presentation.mp3
  24. https://prod1.novartis.com/sites/novartis_com/files/q2-2024-media-release-en.pdf
  25. https://prod1.novartis.com/sites/novartis_com/files/q2-2024-media-release-de.pdf
  26. https://prod1.novartis.com/sites/novartis_com/files/q2-2024-media-release-fr.pdf
  27. https://prod1.novartis.com/sites/novartis_com/files/2024-07-interim-financial-report-en.pdf
  28. https://edge.media-server.com/mmc/p/a2y6rkfr
  29. https://prod1.novartis.com/sites/novartis_com/files/2024-07/q2-2024-investor-presentation.mp3
  30. https://prod1.novartis.com/sites/novartis_com/files/q2-2024-investor-presentation.pdf
  31. https://prod1.novartis.com/investors/financial-data/quarterly-results/2024-q2-transcript
  32. https://prod1.novartis.com/sites/novartis_com/files/novartis-q2-2024-impact-and-sustainability-update.pdf
  33. https://edge.media-server.com/mmc/p/3xi5zz7j/
  34. https://prod1.novartis.com/sites/novartis_com/files/2024-novartis-asco-investor-event-presentation.pdf
  35. https://prod1.novartis.com/news/media-releases/novartis-scemblix-phase-iii-data-first-show-superior-efficacy-favorable-safety-and-tolerability-profile-vs-standard-care-tkis-adults-newly-diagnosed-cml
  36. https://prod1.novartis.com/sites/novartis_com/files/q1-2024-media-release-en.pdf
  37. https://prod1.novartis.com/sites/novartis_com/files/q1-2024-media-release-de.pdf
  38. https://prod1.novartis.com/sites/novartis_com/files/q1-2024-media-release-fr.pdf
  39. https://prod1.novartis.com/sites/novartis_com/files/2024-04-interim-financial-report-en.pdf
  40. https://edge.media-server.com/mmc/p/dngt7jjp
  41. https://prod1.novartis.com/sites/novartis_com/files/2024-04/q1-2024-investor-presentation.mp3
  42. https://prod1.novartis.com/sites/novartis_com/files/q1-2024-investor-presentation.pdf
  43. https://prod1.novartis.com/investors/financial-data/quarterly-results/2024-q1-transcript
  44. https://prod1.novartis.com/sites/novartis_com/files/novartis-q1-2024-impact-and-sustainability-update.pdf
  45. https://prod1.novartis.com/investors/shareholder-information/general-meetings
  46. https://prod1.novartis.com/sites/novartis_com/files/q4-2023-media-release-en.pdf
  47. https://prod1.novartis.com/sites/novartis_com/files/q4-2023-media-release-de.pdf
  48. https://prod1.novartis.com/sites/novartis_com/files/q4-2023-media-release-fr.pdf
  49. https://prod1.novartis.com/sites/novartis_com/files/2024-01-interim-financial-report-en.pdf
  50. https://prod1.novartis.com/sites/novartis_com/files/2024-02/q4-2023-investor-presentation.mp3
  51. https://prod1.novartis.com/sites/novartis_com/files/q4-2023-investor-presentation.pdf
  52. https://prod1.novartis.com/investors/financial-data/quarterly-results/2023-q4-and-full-year-results-transcript
  53. https://prod1.novartis.com/sites/novartis_com/files/novartis-q4-2023-impact-and-sustainability-update.pdf
  54. https://prod1.novartis.com/sites/novartis_com/files/novartis-target-patient-populations-2023.pdf
  55. https://prod1.novartis.com/sites/novartis_com/files/2024-jpm-novartis-strategy-growth-update.pdf
  56. https://prod1.novartis.com/sites/novartis_com/files/2024-01/2024-jpm-novartis-strategy-growth-update.mp3
  57. https://prod1.novartis.com/news/jp-morgan-healthcare-conference-2024
  58. https://prod1.novartis.com/node/662281/printable/print
  59. https://prod1.novartis.com/node/662281/printable/pdf